Lemaitre Vascular Inc. logo

Lemaitre Vascular Inc. (LMAT)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
84. 53
-1.17
-1.37%
$
1.89B Market Cap
46.73 P/E Ratio
0.64% Div Yield
132,622 Volume
1.65 Eps
$ 85.7
Previous Close
Day Range
83.6 86.96
Year Range
71.42 105.55
Want to track LMAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days

Summary

LMAT closed Friday lower at $84.53, a decrease of 1.37% from Thursday's close, completing a monthly decrease of -0.02% or $0.02. Over the past 12 months, LMAT stock lost -8.6%.
LMAT pays dividends to its shareholders, with the most recent payment made on Dec 04, 2025. The next estimated payment will be in In 2 months on Mar 04, 2026 for a total of $0.2.
The last earnings report, released on Nov 06, 2025, exceeded the consensus estimates by 0.18%. On average, the company has surpassed earnings expectations by 0.07%, based on the last three reports. The next scheduled earnings report is due on Feb 19, 2026.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

LMAT Chart

Similar

Innodata Inc.
$ 57.78
-0.98%
Navitas Semiconductor Corp
$ 9.48
+0.32%
AtriCure, Inc.
$ 39.86
+1.55%
Applied Optoelectronics, Inc.
$ 26.59
+1.33%
Shoals Technologies Group, Inc.
$ 8.03
+1.26%
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)

3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 3 weeks ago
LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates

LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.49 per share a year ago.

Zacks | 1 month ago
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 3 months ago

Lemaitre Vascular Inc. (LMAT) FAQ

What is the stock price today?

The current price is $84.53.

On which exchange is it traded?

Lemaitre Vascular Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is LMAT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.64%.

What is its market cap?

As of today, the market cap is 1.89B.

What is the earnings per share?

The EPS is 0.66.

When is the next earnings date?

The next earnings report will release on Feb 19, 2026.

Has Lemaitre Vascular Inc. ever had a stock split?

No, there has never been a stock split.

Lemaitre Vascular Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
George W. LeMaitre CEO
NASDAQ (NMS) Exchange
525558201 CUSIP
US Country
651 Employees
20 Nov 2025 Last Dividend
- Last Split
19 Oct 2006 IPO Date

Overview

LeMaitre Vascular, Inc. is a global company focused on the design, manufacture, and marketing of medical devices and implants for vascular surgery. Initially founded as Vascutech, Inc., the company transitioned to its current name in April 2001. With its beginnings in 1983 and headquartered in Burlington, Massachusetts, LeMaitre Vascular stands as a pioneer in the vascular health sector. It offers a diverse range of products, including devices for blood vessel viewing, blood clot removal, and vascular reconstruction, catering to the needs of surgeons and patients worldwide. The company’s approach combines innovative technology with practical applications in vascular surgery, distributing its products through a direct sales force and a network of distributors.

Products and Services

  • Human Cadaver Tissue Cryopreservation Services: Provides preservation services for human cadaver tissues, making them available for various medical uses.
  • Angioscope: A fiberoptic catheter for viewing the inside of blood vessels, aiding in diagnostics and surgery planning.
  • Embolectomy Catheters: Designed for the removal of blood clots from arteries to restore normal blood flow and prevent tissue damage.
  • Thrombectomy Catheters: Specialized catheters for removing thrombi in the venous system, essential in treating venous thromboembolism.
  • Occlusion Catheters: Temporarily occlude blood flow to facilitate various surgical procedures without significant blood loss.
  • Perfusion Catheters: Allow for the delivery of blood and other fluids into the vasculature, crucial for maintaining tissue viability during surgery.
  • Artegraft Biologic Graft: A bovine carotid artery graft used primarily for dialysis access, offering a durable alternative to synthetic grafts.
  • XenoSure Biologic Patches: Used for vessel closure after surgical interventions, promoting natural healing and vessel function restoration.
  • VascuCel and CardioCel Biologic Patches: Biologic patches for vessel, heart, and neonatal repairs, made to integrate seamlessly with the body’s tissues.
  • Carotid Shunts: Temporarily divert blood to the brain during carotid endarterectomy procedures, ensuring cerebral protection.
  • Biosynthetic Vascular Graft: Indicated for lower extremity bypass and dialysis access, combining the benefits of synthetic and biologic graft materials.
  • Vascular Grafts: Used to bypass or replace diseased arteries, these grafts are critical in restoring normal blood flow to affected limbs.
  • Radiopaque Tape: A medical-grade tape that helps surgeons and interventionalists locate vascular tributaries or lesions beneath the skin.
  • Valvulotomes: Instruments for modifying the saphenous vein to function as an artificial artery, a vital step in some bypass procedures.
  • Closure Systems: Provide an alternative to sutures for attaching vessels, utilizing titanium clips for a secure, leak-proof connection.

Contact Information

Address: 63 Second Avenue
Phone: 781 221 2266